Scoop: Novartis disbands its pioneering cell and gene therapy unit
Novartis is dissolving its high-profile cell and gene therapy unit operating under the guiding hand of Usman “Oz” Azam, Endpoints has learned.
Azam has issued …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.